Vor Biopharma CEO Robert MBBS' 2021 pay falls 40% to $1.7M
Vor Biopharma reports 2021 executive compensation
By ExecPay News
Published: April 28, 2022
Vor Biopharma reported fiscal year 2021 executive compensation information on April 28, 2022.
In 2021, four executives at Vor Biopharma received on average a compensation package of $834K, a 52% decrease compared to previous year.
Average pay of disclosed executives at Vor Biopharma
Robert Ang, M.B.B.S, Chief Executive Officer, received $1.7M in total, which decreased by 40% compared to 2020. 55% of MBBS' compensation, or $919K, was in option awards. MBBS also received $219K in non-equity incentive plan, $508K in salary, as well as $18K in other compensation.
Christopher Slapak, Chief Medical Officer, received a compensation package of $591K, which decreased by 52% compared to previous year. 72% of the compensation package, or $428K, was in salary.
Tirtha Chakraborty, Chief Scientific Officer, earned $541K in 2021, a 54% decrease compared to previous year.
Nathan Jorgensen, Chief Financial Officer, received $539K in 2021.
Related executives
You may also like
Source: SEC filing on April 28, 2022.